Role of Previous Malignancy History in Clinical Outcomes in Patients with Initially Diagnosed Non-Muscle Invasive Bladder Cancer-Reference-Cited by-同舟云学术

Role of Previous Malignancy History in Clinical Outcomes in Patients with Initially Diagnosed Non-Muscle Invasive Bladder Cancer

Published:2021-03-05 Issue:9 Volume:28 Page:5349-5359
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Kufukihara Ryohei,Kikuchi Eiji,Ogihara Koichiro,Shigeta Keisuke,Yanai Yoshinori,Takamatsu Kimiharu,Ide Hiroki,Oyama Masafumi,Asakura Hirotaka,Mizuno Ryuichi,Oya Mototsugu

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-021-09750-0.pdf

Reference28 articles.

1. DeGeorge KC, Holt HR, Hodges SC. Bladder cancer: diagnosis and treatment. Am Fam Phys. 2017;96:507–14.

2. Kamat AM, Hahn NM, Efstathiou JA, et al. Bladder cancer. Lancet. 2016;388:2796–810.

3. Keegan THM, Bleyer A, Rosenberg AS, Li Q, Goldfarb M. Second primary malignant neoplasms and survival in adolescent and young adult cancer survivors. JAMA Oncol. 2017;3:1554–7.

4. Deng L, Harðardottír H, Song H, et al. Mortality of lung cancer as a second primary malignancy: a population-based cohort study. Cancer Med. 2019;8:3269–77.

5. Anderson JK, Alanee S, Lindgren B, Slaton J. The risk of bladder cancer in patients diagnosed with other primary neoplasms: analysis of the SEER database. Urol Oncol. 2013;31:862–5.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of previous malignancy at diagnosis on oncological outcomes of upper tract urothelial carcinoma;BMC Urology;2023-03-29

2. The impact of smoking on recurrence and progression of non-muscle invasive bladder cancer: a systematic review and meta-analysis;Journal of Cancer Research and Clinical Oncology;2022-11-21

3. Impact of Androgen Suppression Therapy on the Risk and Prognosis of Bladder Cancer: A Systematic Review and Meta-Analysis;Frontiers in Oncology;2021-12-14

4. STC1 is a Novel Biomarker Associated with Immune Characteristics and Prognosis of Bladder Cancer;International Journal of General Medicine;2021-09

5. ASO Author Reflections: Previous History of Non-urothelial Malignancy May Provide Predictive Information of Worse Clinical Outcome for Initially Diagnosed Non-Muscle Invasive Bladder Cancer;Annals of Surgical Oncology;2021-03-27